Overview
Molecular Neurodegeneration, published by BioMed Central (United Kingdom), published 499 papers in 2021–2025, and its papers received 25,328 citations in those years. Its h-index is 168 and its two-year mean citedness is 18.07. On the ITS Journal Score it ranks #279 of 62,158 ranked journals and #65 of 8,757 in Medicine.
Key figures
Citations count every citation the journal's papers received in these years, including citations to older papers. Two-year mean citedness is OpenAlex's measure of how often recent papers are cited; it is similar in idea to, but not the same as, an impact factor.
Papers and citations by year
| Year | Papers | Citations received | Open-access papers |
|---|---|---|---|
| 2020 | 67 | 8,755 | 67 |
| 2021 | 84 | 7,809 | 84 |
| 2022 | 85 | 6,808 | 85 |
| 2023 | 100 | 5,334 | 100 |
| 2024 | 100 | 3,201 | 100 |
| 2025 | 130 | 2,176 | 130 |
What it publishes
The leading research topics of its papers (OpenAlex topic classification). Select a topic to find other journals that publish on it.
Similar journals
Ranked journals that publish on the same topics.
| Journal | Field | Score | Papers 2021–2025 | Open access |
|---|---|---|---|---|
| Alzheimer s Research & Therapy | Medicine | 86.5 | 1,197 | 100% |
| Journal of Alzheimer s Disease | Medicine | 81.1 | 4,186 | 48% |
| Journal of Alzheimer s Disease Reports | Medicine | 68.4 | 571 | 100% |
| Current Alzheimer Research | Medicine | 71.0 | 439 | 17% |
| Alzheimer s & Dementia Translational Research & Clinical Interventions | Medicine | 77.0 | 583 | 100% |
| The Journal of Prevention of Alzheimer s Disease | Medicine | 78.9 | 808 | 100% |
| Translational Neurodegeneration | Medicine | 85.0 | 307 | 100% |
| Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring | Medicine | 73.5 | 738 | 100% |
Compare with similar journals (side by side with the two closest journals above)
Identity and sources
- ISSN-L: 1750-1326
- Print ISSN: 1750-1326
- Publisher: BioMed Central
- Listed in DOAJ: Yes (checked against DOAJ)
- Crossref: ISSN found in Crossref
- OpenAlex: S40861184
- Journal website: www.molecularneurodegeneration.com
Figures come from OpenAlex (papers, citations, h-index, topics), Crossref (ISSN check) and DOAJ (open-access listing and fees). They change as records are corrected, so treat them as a dated snapshot. This page does not state whether the journal is indexed in Scopus, Web of Science or PubMed.
Questions
What is the ITS Journal Score of Molecular Neurodegeneration?
It is 89.7 out of 100, which places it #279 among ranked journals. The score combines citation impact (45%), h-index (35%) and size (20%) from open OpenAlex data.
What is the impact factor of Molecular Neurodegeneration?
This site does not publish Journal Impact Factors, which belong to Clarivate. As an open alternative, its two-year mean citedness in OpenAlex is 18.07.
Is Molecular Neurodegeneration open access?
100% of its papers from 2021–2025 are recorded as open access, and it is listed in DOAJ.
Does Molecular Neurodegeneration charge a publication fee?
DOAJ records an article processing charge of 2,990 EUR. Check the journal's website for the current fee and any waivers.